Author name: yc89192889

JY Biomed and YC Biotech Announce IRB Submission for a Regenerative Medicine Clinical Study for Parkinson’s Disease 

In April 2025, JY Biomed Inc. and YC Biotech Inc. jointly announced the submission of their collaborative regenerative medicine clinical study for Parkinson’s Disease (PD) to the Joint Institutional Review Board of Taipei Medical University and its affiliated hospitals.  This study centers on the use of mesenchymal stem cells (MSCs) to evaluate their potential therapeutic […]

JY Biomed and YC Biotech Announce IRB Submission for a Regenerative Medicine Clinical Study for Parkinson’s Disease  Read More »

YC Biotech Launches Preclinical Study on Exosome-Based Hair Regeneration, Expanding into Regenerative Medicine

Taipei City | Date: February 4, 2025 regeneratiYC Biotech Co., Ltd. announced recently that it will conduct an innovative animal study on hair follicle regeneration, scheduled to begin in February 2025. This nearly year-long research will evaluate the efficacy of hair follicle stem cell exosomes in promoting hair growth. This prospective study will conduct a

YC Biotech Launches Preclinical Study on Exosome-Based Hair Regeneration, Expanding into Regenerative Medicine Read More »

YC Biotech and 3D Global Biotech Expand into Osteoarthritis Treatment with Innovative Injectable Clinical Research

Taipei City | Date: January 16, 2025 As Taiwan’s population continues to age, osteoarthritis has become an increasing burden on patients’ mobility and quality of life, leading to a growing demand for effective treatments. To improve patient well-being, YC Biotech Co., Ltd. is launching an innovative clinical study focused on knee osteoarthritis treatment. The study

YC Biotech and 3D Global Biotech Expand into Osteoarthritis Treatment with Innovative Injectable Clinical Research Read More »

YC Biotech Partners with Odawara Hakone Kenshin Clinic to Create a Precision Medicine Ecosystem

Based on their long-standing academic exchange foundation, YC Biotech and Odawara Hakone Kenshin Clinic have jointly created a precision medicine ecosystem that integrates the strengths of both Taiwan and Japan. In addition to providing services through Odawara Hakone Kenshin Clinic’s state-of-the-art equipment, YC Biotech has exclusively introduced leading Taiwanese biotech brand Ji Yan Biomedical’s stem

YC Biotech Partners with Odawara Hakone Kenshin Clinic to Create a Precision Medicine Ecosystem Read More »

YC Biotech Pioneers Aesthetic Medicine Market with Hyaluronic Acid Clinical Data Research Initiative

Taipei City | Date: January 14, 2025 YC Biotech Co., Ltd. is actively expanding its clinical research footprint in the field of aesthetic medicine. The company recently announced the launch of an innovative clinical research project at Shuang Ho Hospital, part of the Taipei Medical University Healthcare System. This study will focus on evaluating the

YC Biotech Pioneers Aesthetic Medicine Market with Hyaluronic Acid Clinical Data Research Initiative Read More »

Clinical Application Trial of OMNIHAIR Hair Care Series Officially Commences

Taipei City – January 7, 2025 Dr. Lee, renowned for her expertise in treating hair loss, was specially invited to lead this trial due to her exceptional professional background and achievements. A graduate of Taipei Medical University with advanced training at Harvard University, Dr. Lee previously served as Director of the Medical Aesthetics and Cosmetics

Clinical Application Trial of OMNIHAIR Hair Care Series Officially Commences Read More »

YC Biotech to Launch Innovative Stem Cell and Exosome Research at Shuang Ho Hospital

Taipei City | Date: January 2, 2025 YC Biotech Co., Ltd. has built a strong collaborative relationship with Shuang Ho Hospital, which is part of the Taipei Medical University Healthcare System. In 2025, this partnership will advance further with research focused on stem cell cultivation and exosome technology development. The study is set to begin

YC Biotech to Launch Innovative Stem Cell and Exosome Research at Shuang Ho Hospital Read More »

YC Biotech Co., Ltd. and Taipei Medical University Jointly Launch the “Global Market Analysis of Biomedical Implants” Industry-Academia Collaboration Project

January 1, 2025, Taipei — YC Biotech Co., Ltd. (hereinafter referred to as “YC Biotech”) and Taipei Medical University (hereinafter referred to as “TMU”) officially announced today that they will jointly execute the “Global Market Analysis of Biomedical Implants” industry-academia collaboration project from January 1, 2025, to December 31, 2025. This project aims to integrate

YC Biotech Co., Ltd. and Taipei Medical University Jointly Launch the “Global Market Analysis of Biomedical Implants” Industry-Academia Collaboration Project Read More »

YC Biotech Establishes Operations in Shuang Ho Biotech Park, Advancing Cross-Disciplinary Collaboration in Academia and Medicine

New Taipei City | Date: November 5, 2024 YC Biotech CO., LTD. is proud to announce its expansion into Taipei Medical University’s Shuang Ho Biotech Park, with plans to develop state-of-the-art laboratories dedicated to driving innovation in precision medicine and regenerative medicine. This move signifies a significant step forward in the collaboration between YC Biotech,

YC Biotech Establishes Operations in Shuang Ho Biotech Park, Advancing Cross-Disciplinary Collaboration in Academia and Medicine Read More »